Susquehanna International Group
HEPA

Susquehanna International Group’s Hepion Pharmaceuticals HEPA Stock Holding History

Susquehanna International Group’s Portfolio HEPA Stock Details HEPA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-521
Closed -$12.2K – 12869
2024
Q4 		$12.2K Buy
521
+228
+78% +$7.12K ﹤0.01% 11969
2024
Q3 		$9.81K Hold
293
– – ﹤0.01% 11723
2024
Q2 		$15.8K Hold
293
– – ﹤0.01% 11710
2024
Q1 		$36.4K Hold
293
– – ﹤0.01% 11655
2023
Q4 		$47.9K Hold
293
– – ﹤0.01% 11731
2023
Q3 		$73K Hold
293
– – ﹤0.01% 11120
2023
Q2 		$154K Buy
293
+138
+89% +$84.7K ﹤0.01% 10553
2023
Q1 		$120K Buy
155
+59
+61% +$43.6K ﹤0.01% 11128
2022
Q4 		$28.8K Sell
96
-69
-42% -$29.2K ﹤0.01% 11634
2022
Q3 		$84K Buy
165
+71
+76% +$43.4K ﹤0.01% 11841
2022
Q2 		$54K Buy
94
+45
+92% +$37.5K ﹤0.01% 11936
2022
Q1 		$64K Sell
49
-40
-45% -$44.2K ﹤0.01% 12182
2021
Q4 		$101K Sell
89
-26
-23% -$35.6K ﹤0.01% 12145
2021
Q3 		$176K Sell
115
-123
-52% -$197K ﹤0.01% 11630
2021
Q2 		$472K Sell
238
-116
-33% -$212K ﹤0.01% 9730
2021
Q1 		$651K Buy
354
+314
+785% +$688K ﹤0.01% 8851
2020
Q4 		$88K Buy
+40
New +$104K ﹤0.01% 10558
2019
Q3 		– Sell
-11
Closed -$44K – 10429
2019
Q2 		$44K Buy
+11
New +$112K ﹤0.01% 9869
2018
Q1 		– Hold
0
– -$8K – 9654
2017
Q4 		– Hold
0
– – – 9124

Other funds holding HEPA

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group's HEPA Position: Q1 2025 in Review

Susquehanna International Group sold out of Hepion Pharmaceuticals (HEPA) in Q1 2025, closing a stake of 521 shares — an estimated $12.2K sold.

Susquehanna International Group first reported a position in HEPA in Q2 2019 and held it in 18 quarters. The position peaked at $651K in Q1 2021. 16 funds tracked by Wall St. Rank hold HEPA as of Q1 2025.

  • Susquehanna International Group reported no remaining Hepion Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Susquehanna International Group sold 521 Hepion Pharmaceuticals shares in Q1 2025, an estimated $12.2K.
  • Susquehanna International Group first reported a position in Hepion Pharmaceuticals in Q2 2019 and held it in 18 quarters.
  • Susquehanna International Group's Hepion Pharmaceuticals position peaked at $651K in Q1 2021.
  • 16 funds tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q1 2025.

Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.